{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:57:09Z","timestamp":1774490229854,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"am","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["2416"],"award-info":[{"award-number":["2416"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H03770"],"award-info":[{"award-number":["20H03770"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.lungcan.2022.11.015","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T14:29:12Z","timestamp":1669213752000},"page":"36-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A novel cell-based assay for the high-throughput screening of epithelial\u2013mesenchymal transition inhibitors: Identification of approved and investigational drugs that inhibit epithelial\u2013mesenchymal transition"],"prefix":"10.1016","volume":"175","author":[{"given":"Hiroyuki","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshi","family":"Menju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiya","family":"Toyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohisa","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misa","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyuki","family":"Tamari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yojiro","family":"Yutaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satona","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Ohsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Hamaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Date","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2022.11.015_b0005","unstructured":"cancer-facts-and-figures-2021 https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2021\/cancer-facts-and-figures-2021.pdf, (n.d.)."},{"key":"10.1016\/j.lungcan.2022.11.015_b0010","doi-asserted-by":"crossref","unstructured":"A.M. Noone, K.A. Cronin, S.F. Altekruse, N. Howlader, D.R. Lewis, V.I. Petkov, L. Penberthy, Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992-2013, Cancer Epidemiol. Biomarkers Prev. 26 (2017) 632\u2013641. 10.1158\/1055-9965.EPI-16-0520.","DOI":"10.1158\/1055-9965.EPI-16-0520"},{"key":"10.1016\/j.lungcan.2022.11.015_b0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-3-319-24932-2_3","article-title":"Epithelial mesenchymal transition in aggressive lung cancers","author":"Mittal","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lungcan.2022.11.015_b0020","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/cam4.556","article-title":"Association between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma","volume":"4","author":"Sowa","year":"2015","journal-title":"Cancer Med."},{"key":"10.1016\/j.lungcan.2022.11.015_b0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.lungcan.2018.12.001","article-title":"Prognostic impact of microscopic vessel invasion and visceral pleural invasion and their correlations with epithelial\u2013mesenchymal transition, cancer stemness, and treatment failure in lung adenocarcinoma","volume":"128","author":"Neri","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2022.11.015_b0030","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.2147\/CMAR.S200819","article-title":"Statins may have double-edged effects in patients with lung adenocarcinoma after lung resection","volume":"11","author":"Nishikawa","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.lungcan.2022.11.015_b0035","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.21873\/anticanres.14311","article-title":"Tranilast inhibits TGF-\u03b21-induced epithelial-mesenchymal transition and invasion\/metastasis via the suppression of smad4 in human lung cancer cell lines","volume":"40","author":"Takahashi","year":"2020","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lungcan.2022.11.015_b0040","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s11748-021-01595-4","article-title":"Lung cancer and epithelial-mesenchymal transition","volume":"69","author":"Menju","year":"2021","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lungcan.2022.11.015_b0045","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/cr.2009.5","article-title":"TGF-\u0392-induced epithelial to mesenchymal transition","volume":"19","author":"Xu","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.lungcan.2022.11.015_b0050","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3892\/ijo.2015.2816","article-title":"Role of TGF\u03b2 in regulation of the tumor microenvironment and drug delivery (review)","volume":"46","author":"Papageorgis","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lungcan.2022.11.015_b0055","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.0604348103","article-title":"Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries","volume":"103","author":"Inglese","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lungcan.2022.11.015_b0060","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.18632\/oncotarget.6995","article-title":"Identification of approved and investigational drugs that inhibit hypoxia-inducible factor-1 signaling","volume":"7","author":"Hsu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lungcan.2022.11.015_b0065","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lungcan.2022.11.015_b0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2022.11.015_b0075","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2217\/fon.09.90","article-title":"Mechanisms of the epithelial-mesenchymal transition by TGF-\u03b2","volume":"5","author":"Wendt","year":"2009","journal-title":"Future Oncol."},{"key":"10.1016\/j.lungcan.2022.11.015_b0080","doi-asserted-by":"crossref","DOI":"10.6000\/1927-3037.2012.01.01.02","article-title":"Cell-based assays in high-throughput screening for drug discovery","author":"Yang","year":"2012","journal-title":"Int. J. Biotechnol. Wellness Ind."},{"key":"10.1016\/j.lungcan.2022.11.015_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-60327-545-3_1","article-title":"Introduction: cell-based assays for high-throughput screening","volume":"486","author":"An","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.lungcan.2022.11.015_b0090","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12033-010-9251-z","article-title":"Cell-based assays for high-throughput screening","volume":"45","author":"An","year":"2010","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.lungcan.2022.11.015_b0095","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7220","article-title":"Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy","volume":"6","author":"Kenny","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2022.11.015_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162394","article-title":"A novel high-throughput3d screening system for EMT inhibitors: A pilot screening discovered the EMT inhibitory activity of CDK2 inhibitor SU9516","volume":"11","author":"Arai","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2022.11.015_b0105","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nrd3869","article-title":"Drug repositioning for Alzheimer\u2019s disease","volume":"11","author":"Corbett","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lungcan.2022.11.015_b0110","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13140-2","article-title":"Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1\/E-cadherin switch","volume":"10","author":"Miro","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2022.11.015_b0115","doi-asserted-by":"crossref","unstructured":"A. Hayakawa, H. Suzuki, Y. Kamei, S.-I. Tanuma, J. Magae, Cladribine enhances apoptotic cell death in lung carcinoma cells over-expressing DNase g g, 2011.","DOI":"10.1248\/bpb.34.1001"},{"key":"10.1016\/j.lungcan.2022.11.015_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(17)30679-4","article-title":"Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial","volume":"18","author":"Planchard","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2022.11.015_b0125","doi-asserted-by":"crossref","first-page":"950","DOI":"10.15252\/emmm.201607265","article-title":"\u03b3-Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct","volume":"9","author":"Ran","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.lungcan.2022.11.015_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2012.01.021","article-title":"Notch signaling mediates TGF-\u03b21-induced epithelial-mesenchymal transition through the induction of Snai 1","volume":"44","author":"Matsuno","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.lungcan.2022.11.015_b0135","article-title":"Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis","volume":"5","author":"Yuan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lungcan.2022.11.015_b0140","doi-asserted-by":"crossref","first-page":"e608","DOI":"10.1002\/onco.13627","article-title":"Gamma secretase inhibitors in cancer: A current perspective on clinical performance","volume":"26","author":"McCaw","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.lungcan.2022.11.015_b0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10555-008-9169-0","article-title":"EMT, the cytoskeleton, and cancer cell invasion","volume":"28","author":"Yilmaz","year":"2009","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.lungcan.2022.11.015_b0150","doi-asserted-by":"crossref","unstructured":"J.Y. Shih, M.F. Tsai, T.H. Chang, Y.L. Chang, A. Yuan, C.J. Yu, S.B. Lin, G.Y. Liou, M.L. Lee, J.J.W. Chen, T.M. Hong, S.C. Yang, J.L. Su, Y.C. Lee, P.C. Yang, Transcription repressor Slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma, Clin. Cancer Res. 11 (2005) 8070\u20138078. 10.1158\/1078-0432.CCR-05-0687.","DOI":"10.1158\/1078-0432.CCR-05-0687"},{"key":"10.1016\/j.lungcan.2022.11.015_b0155","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ejcts.2011.01.023","article-title":"A comparison of Twist and E-cadherin protein expression in primary non-small-cell lung carcinoma and corresponding metastases","volume":"39","author":"Wang","year":"2011","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.lungcan.2022.11.015_b0160","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6660","article-title":"Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis","volume":"5","author":"Liu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2022.11.015_b0165","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2015.2861","article-title":"Critical contribution of MCL-1 in EMT-associated chemo-resistance in A549 non-small cell lung cancer","volume":"46","author":"Toge","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lungcan.2022.11.015_b0170","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-07-2248","article-title":"Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer","volume":"14","author":"Engelman","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2022.11.015_b0175","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-14-0110","article-title":"The TGF\u03b2-miR200-MIG6 pathway orchestrates the EMT-associated kinase switch that induces resistance to EGFR inhibitors","volume":"74","author":"Izumchenko","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2022.11.015_b0180","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/onc.2010.215","article-title":"EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer","volume":"29","author":"Singh","year":"2010","journal-title":"Oncogene"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222006882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222006882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:02:24Z","timestamp":1759237344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500222006882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":36,"alternative-id":["S0169500222006882"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.11.015","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel cell-based assay for the high-throughput screening of epithelial\u2013mesenchymal transition inhibitors: Identification of approved and investigational drugs that inhibit epithelial\u2013mesenchymal transition","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}